Artificial Liver Support with CytoSorb and MARS in Liver Failure: A Retrospective Propensity Matched Analysis.

Mihai PopescuCorina DavidAlexandra MarcuMihaela Roxana OlitaMariana MihailaDana Tomescu

Published in: Journal of clinical medicine (2023)

In conclusion, our results show a potential benefit of CytoSorb in rebalancing liver functional tests in patients with liver failure compared to MARS but the exact effects on patient outcome, including hospital length of stay and survival, should be further investigated in randomized control trials.

Keyphrases

liver failure
hepatitis b virus
double blind
healthcare
open label
case report
phase iii
density functional theory
acute care
human health
free survival